Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Hair loss significantly affects European men's self-esteem and concern about aging, with these feelings being common across four countries.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Treating hair loss in both men and women is effective and improves quality of life.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

Both surgical and non-surgical hair loss treatments lack a standard treatment plan and sufficient patient satisfaction data.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

650 nm red light helps hair grow and prevents hair loss by affecting certain genes and biological processes.

One session of Low Level Laser Therapy before hair transplantation doesn't significantly improve hair growth.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

LED therapy can safely and effectively regrow eyebrows in people with frontal fibrosing alopecia.

Lasers can be effective for treating hair loss from alopecia areata.

The 532 nm laser effectively reduces facial vascular and pigmented lesions, with the VISIA system reliably assessing treatment results.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Helmets used in acupuncture and light therapy can affect brain blood flow, hair growth, and may improve brain diseases and cognitive functions.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

A new hair loss treatment was created using minoxidil and tretinoin in stable niosomes, which effectively released the drugs over time.

The supplement may help hair growth and is safe, but more research is needed.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

New regenerative therapies show promise for treating hair loss.

Non-drug therapies show promise for hair regrowth but need more research.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.